21:51:41 EDT Tue 06 Jun 2023
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

SEC defendant Palatnik denies wrongdoing

2022-09-13 21:02 ET - Street Wire

Also Street Wire (C-CNFA) Canafarma Hemp Products Corp

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

Igor Palatnik, one of those charged in New York for a fraud at Canadian Securities Exchange listing Canafarma Hemp Products Corp., denies that he did anything wrong, and says that those behind the scheme remain unscathed. He claims that two former associates of his have managed to avoid prison by "pointing their fingers" at him. They provided prosecutors with the bulk of the information that led to the charges, he contends.

The accusations from Mr. Palatnik come as part of a case that the government has been pursuing against him and another man, Vitaly Fargesen, for misappropriating Canafarma's money. Prosecutors claim that the men, who were Canafarma's founders, misappropriated the money through bogus consulting agreements while lying to investors about the company's prospects. The men took $4-million through the scheme, prosecutors say. (All figures are in U.S. dollars.)

The case has yet to go to trial, and Mr. Palatnik has made it clear that he denies any wrongdoing. He claims that two men, who he names as Frank Barone and Kirill Chumenko, "stole millions from Canafarma and are avoiding prison by pointing their fingers" at him and Mr. Fargesen. The men were only mentioned in the indictment as anonymous co-conspirators, and not named as defendants, he says.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2023 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.